Promotion of formation of amyloid fibrils by aluminium adenosine triphosphate (AlATP)

被引:55
作者
Exley, C [1 ]
Korchazhkina, OV [1 ]
机构
[1] Univ Keele, Sch Chem, Birchall Ctr Inorgan Chem & Mat Sci, Keele ST5 5BG, Staffs, England
基金
英国惠康基金;
关键词
amyloid fibrils; Alzheimer's disease; amyloidoses; aluminium adenosine triphosphate;
D O I
10.1016/S0162-0134(01)00171-4
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The formation of amyloid fibrils is considered to be an important step in the aetiology of Alzheimer's disease and other amyloidoses. Fibril formation in vitro has been shown to depend on many different factors including modifications to the amino acid profile of fibrillogenic peptides and interactions with both large and small molecules of physiological significance. How these factors might contribute to amyloid fibril formation in vivo is not clear as very little is known about the promotion of fibril formation in undersaturated solutions of amyloidogenic peptides. We have used thioflavin T fluorescence and reverse phase high performance liquid chromatography to show that ATP. and in particular AIATP. promoted the formation of thioflavin T-reactive fibrils of beta amyloid and, an unrelated amyloidogenic peptide, amylin. Evidence is presented that induction of fibril formation followed the complexation of AlATP by one or more monomers of the respective peptide. However, the complex formed could not be identified directly and it is suggested that AIATP might be acting as a chaperone in the assembly of amyloid fibrils. The effect of AIATP was not mimicked by either AlADP or AlAMP. However, it was blocked by suramin, a P2 ATP receptor antagonist, and this has prompted us to speculate that the precursor proteins to beta amyloid and amylin may be substrates or receptors for ATP in vivo. (C) 2001 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:215 / 224
页数:10
相关论文
共 52 条
  • [11] Biological availability of aluminum in commercial ATP
    Exley, C
    Birchall, JD
    [J]. JOURNAL OF INORGANIC BIOCHEMISTRY, 1996, 63 (04) : 241 - 252
  • [12] ATP-promoted amyloidosis of an amyloid beta peptide
    Exley, C
    [J]. NEUROREPORT, 1997, 8 (15) : 3411 - 3414
  • [13] ALUMINUM, BETA-AMYLOID AND NONENZYMATIC GLYCOSYLATION
    EXLEY, C
    SCHLEY, L
    MURRAY, S
    HACKNEY, CM
    BIRCHALL, JD
    [J]. FEBS LETTERS, 1995, 364 (02) : 182 - 184
  • [14] ALUMINUM INHIBITION OF HEXOKINASE-ACTIVITY IN-VITRO - A STUDY IN BIOLOGICAL AVAILABILITY
    EXLEY, C
    PRICE, NC
    BIRCHALL, JD
    [J]. JOURNAL OF INORGANIC BIOCHEMISTRY, 1994, 54 (04) : 297 - 304
  • [15] Modified-peptide inhibitors of amyloid β-peptide polymerization
    Findeis, MA
    Musso, GM
    Arico-Muendel, CC
    Benjamin, HW
    Hundal, AM
    Lee, JJ
    Chin, J
    Kelley, M
    Wakefield, J
    Hayward, NJ
    Molineaux, SM
    [J]. BIOCHEMISTRY, 1999, 38 (21) : 6791 - 6800
  • [16] SURAMIN - POTENT ATPASE INHIBITOR WHICH ACTS ON INSIDE SURFACE OF SODIUM PUMP
    FORTES, PAG
    ELLORY, JC
    LEW, VL
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA, 1973, 318 (02) : 262 - 272
  • [17] ALPHA-1-ANTICHYMOTRYPSIN BINDING TO ALZHEIMER A-BETA PEPTIDES IS SEQUENCE-SPECIFIC AND INDUCES FIBRIL DISAGGREGATION INVITRO
    FRASER, PE
    NGUYEN, JT
    MCLACHLAN, DR
    ABRAHAM, CR
    KIRSCHNER, DA
    [J]. JOURNAL OF NEUROCHEMISTRY, 1993, 61 (01) : 298 - 305
  • [18] ALZHEIMERS-DISEASE - INITIAL REPORT OF THE PURIFICATION AND CHARACTERIZATION OF A NOVEL CEREBROVASCULAR AMYLOID PROTEIN
    GLENNER, GG
    WONG, CW
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1984, 120 (03) : 885 - 890
  • [19] AMYLOID DEPOSITION AS THE CENTRAL EVENT IN THE ETIOLOGY OF ALZHEIMERS-DISEASE
    HARDY, J
    ALLSOP, D
    [J]. TRENDS IN PHARMACOLOGICAL SCIENCES, 1991, 12 (10) : 383 - 388
  • [20] Observation of metastable A beta amyloid protofibrils by atomic force microscopy
    Harper, JD
    Wong, SS
    Lieber, CM
    Lansbury, PT
    [J]. CHEMISTRY & BIOLOGY, 1997, 4 (02): : 119 - 125